Compare VRNS & IRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VRNS | IRTC |
|---|---|---|
| Founded | 2004 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8B | 4.2B |
| IPO Year | 2013 | 2016 |
| Metric | VRNS | IRTC |
|---|---|---|
| Price | $46.09 | $123.07 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 21 | 13 |
| Target Price | $42.75 | ★ $197.92 |
| AVG Volume (30 Days) | ★ 1.4M | 612.7K |
| Earning Date | 04-28-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 61.71 |
| EPS | N/A | ★ N/A |
| Revenue | $270,288,000.00 | ★ $747,138,000.00 |
| Revenue This Year | $18.87 | $19.60 |
| Revenue Next Year | $17.77 | $15.94 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 24.35 | ★ 26.24 |
| 52 Week Low | $19.70 | $100.85 |
| 52 Week High | $63.90 | $210.01 |
| Indicator | VRNS | IRTC |
|---|---|---|
| Relative Strength Index (RSI) | 58.67 | 52.76 |
| Support Level | $31.32 | $112.26 |
| Resistance Level | $49.54 | $129.48 |
| Average True Range (ATR) | 2.01 | 5.52 |
| MACD | 0.37 | -0.33 |
| Stochastic Oscillator | 74.55 | 54.95 |
Varonis Systems is a cybersecurity vendor focused on data privacy and security. The firm is currently undergoing a cloud transition as it weans its on-premises customers over to its cloud products that are delivered as software-as-a-service. The New York-based firm was founded in 2005 and went public in 2014.
iRhythm Holdings Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.